Instead of the original 0.95% rate cut for the Medicare Advantage (MA) program proposed in February, CMS announced on Monday that the MA pay rate for 2016 would be a 1.25% increase.
Instead of the original 0.95% rate cut for the Medicare Advantage (MA) program proposed in February, CMS announced on Monday that the MA pay rate for 2016 would be a 1.25% increase.
Since 2010, MA enrollment has increased 42% to an all-time high of 16 million beneficiaries. Of the entire Medicare population, nearly 30% are enrolled in a MA plan, according to CMS. In addition, the average premium has dropped 6% between 2010 and 2015.
CMS has estimated that with the government’s MA payments increasing 1.25% in 2016, insurers will likely see overall revenue increase 3.25%, according to the agency’s fact sheet on 2016 payment updates.
“These policies strengthen Medicare Advantage for current and future consumers by encouraging higher quality care,” Andy Slavitt, acting CMS Administrator, said in a statement. “As the Medicare Advantage marketplace continues to grow, consumers are getting access to better care through more choice and competition. Seniors and people with disabilities, including the dual-eligible population, will continue to have an extensive choice of plans, affordable premiums, and better and more transparent information about provider networks and pharmacies.”
At the end of February, America’s Health Insurance Plans (AHIP) released a report that found the proposed MA cuts would cause many beneficiaries to lose access to these plans and disrupt their care. Monthly premiums or benefit changes per member could have been as much as $20, according to the calculation by Oliver Wyman, which compiled the report for AHIP.
“The final rate notice took a notable step to provide stable funding for the Medicare Advantage program,” AHIP president and chief executive officer Karen Ignagni said in a statement. However, the lack of action to address policy concerns around providing care for the chronically ill and vulnerable populations could undermine health plans’ efforts to address the needs of these beneficiaries.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More